Supplementary Table S1. Clinical characteristics of 84 ICC patients depending on ALKBH5 expression levels. Supplementary Table S2. Clinical characteristics of 6 ICC specimens receiving immunotherapy. Supplementary Table S3: m6A-seq identified m6A peaks on PD-L1 mRNA. m6A peaks on PD-L1 mRNA and its corresponding primers for quantitative RT-PCR. Supplementary Table S4. m6A peaks in PD-L1 mRNA in m6A-Seq data from GSE87515.